Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1) in patients with obesity and type 2 diabetes: evidence for altered adiponectin signalling
暂无分享,去创建一个
R. Berria | J. Finlayson | L. Mandarino | M. Bajaj | Lily Q. Dong | L. Dong | K. Fujiwara | C. Meyer | V. Sherman | Z. Yi | C. Christ-Roberts | S. Shahani | H. Hwang | E. De Filippis | R. M. Holmes | S. Shahani | P. Sathyanarayana | V. Sherman | K. Fujiwara | R. Holmes | E. D. Filippis | Zhengping Yi | C. Meyer
[1] Lawrence J. Mandarino,et al. Label-free relative quantification of co-eluting isobaric phosphopeptides of insulin receptor substrate-1 by HPLC-ESI-MS/MS , 2010, Journal of the American Society for Mass Spectrometry.
[2] W. Inder,et al. Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone , 2008, Clinical endocrinology.
[3] C. Flynn,et al. Characterization of the Human Skeletal Muscle Proteome by One-dimensional Gel Electrophoresis and HPLC-ESI-MS/MS*S , 2008, Molecular & Cellular Proteomics.
[4] C. Flynn,et al. Global Assessment of Regulation of Phosphorylation of Insulin Receptor Substrate-1 by Insulin In Vivo in Human Muscle , 2007, Diabetes.
[5] W. Schwesinger,et al. Metabolic aspects of bariatric surgery. , 2007, The Medical clinics of North America.
[6] Mark L. Grimes,et al. APPL1 Associates with TrkA and GIPC1 and Is Required for Nerve Growth Factor-Mediated Signal Transduction , 2006, Molecular and Cellular Biology.
[7] Feng Liu,et al. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function , 2006, Nature Cell Biology.
[8] R. Berria,et al. Increased collagen content in insulin-resistant skeletal muscle. , 2006, American journal of physiology. Endocrinology and metabolism.
[9] B. Kemp,et al. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. , 2005, The Journal of clinical endocrinology and metabolism.
[10] 土田 敦之. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity , 2005 .
[11] G. Heigenhauser,et al. AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females. , 2004, The Journal of clinical endocrinology and metabolism.
[12] Steven P Gygi,et al. Large-scale characterization of HeLa cell nuclear phosphoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Testa,et al. Human Follicle-Stimulating Hormone (FSH) Receptor Interacts with the Adaptor Protein APPL1 in HEK 293 Cells: Potential Involvement of the PI3K Pathway in FSH Signaling1 , 2004, Biology of reproduction.
[14] Y. Boirie,et al. Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients , 2004, Diabetologia.
[15] E. Ravussin,et al. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes , 2004, Diabetologia.
[16] Philippe Froguel,et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.
[17] Chawnshang Chang,et al. APPL Suppresses Androgen Receptor Transactivation via Potentiating Akt Activity* , 2003, The Journal of Biological Chemistry.
[18] H. Koistinen,et al. 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. , 2003, Diabetes.
[19] M. Cnop,et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex , 2003, Diabetologia.
[20] H. Lodish,et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl–CoA carboxylase inhibition and AMP-activated protein kinase activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[21] S. Uchida,et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.
[22] S. Maruoka,et al. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. , 2002, European journal of endocrinology.
[23] Russell L Finley,et al. Mediation of the DCC Apoptotic Signal by DIP13α* , 2002, The Journal of Biological Chemistry.
[24] A. Kappes,et al. DECREASED PLASMA ADIPONECTIN CONCENTRATIONS IN WOMEN WITH DYSLIPIDEMIA , 2002 .
[25] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[26] Y. Terauchi,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.
[27] P. Scherer,et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.
[28] T. Funahashi,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .
[29] H. Lodish,et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Kihara,et al. Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.
[31] S. Kihara,et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.
[32] T Nakamura,et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[33] E. Ravussin,et al. Decreased Expression Of apM1 in Omental and Subcutaneous Adipose Tissue of Humans With Type 2 Diabetes , 2000, International journal of experimental diabetes research.
[34] Erica A Golemis,et al. Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2 , 1999, Oncogene.
[35] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[36] T. O’Neill,et al. Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system , 1994, Molecular and cellular biology.
[37] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[38] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.